International Stem Cell Corporation

,International Stem Cell Corporation is a biotechnology company based in Carlsbad, California. The company employs 20 people and generates revenue exceeding $10,000. International Stem Cell Corporation specializes in developing a groundbreaking stem cell technology called "parthenogenesis." This process utilizes unfertilized human eggs to create "parthenogenetic" stem cells (hpSC), which can be "immune-matched" to a vast population. The company aims to establish a global bank of these hpSC lines, known as UniStemCell™, providing immune-matched cells for diverse populations worldwide. The company's hpSC technology avoids the ethical concerns associated with using viable human embryos. ISCO's researchers focus on harnessing the therapeutic potential of hpSC to treat severe diseases affecting the eye, nervous system, and liver, where cell therapy has shown clinical promise but is hindered by the lack of readily available, safe, immune-matched human cells. International Stem Cell Corporation operates under three business divisions: Lifeline Cell Technology, Lifeline Skin Care, and Universal Stem Cell Bank. Their website can be found at intlstemcell.com.